Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and provides a novel diagnostic and treatment target

P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and provides a novel diagnostic and treatment target

US Patent 7217533 · Granted May 15, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Defining actions for data streams via icons2016
Email characterization2014
P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and 2008
P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and 2008
P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and 2008
Detection of onset of antiestrogen resistance in breast cancer1995
Mechanisms of antiestrogen resistance in breast cancer1992